VOA news examines AIDS among marginalized groups in Burma

VOA News examines AIDS among high-risk groups in Burma, also known as Myanmar. "Burma's AIDS epidemic mostly affects marginalized groups, such as the gay community," the news service writes, adding, "About one percent of Burma's population is HIV-positive," but "[a]mong high-risk groups, such as men who have sex with men, health workers estimate as many as 11 percent have HIV." The news service notes, "While Burma's National AIDS Plan has helped stem new infections, it offers almost no help for marginalized groups already living with HIV."

"In a country where homosexuality remains illegal, finding and treating gay patients is a challenge for the few health workers devoted to their treatment," VOA writes. "Kyaw Soe, the ministry of health's HIV officer for Mandalay Division, nevertheless recognizes the risks from not treating these groups," according to the news service. "'There may be laws against homosexuality, but if we look at it from a public health point of view, we have to help these people,' Kyaw [said]," VOA adds (9/10).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Semaglutide reduced mortality in obese patients by lowering infection-related deaths during COVID-19 pandemic